Anixa Biosciences, Inc. (ANIX) short interest & options flow
NASDAQANIX heads into the final days of April trading at $2.88 — down 8% on the week and 4% on Wednesday alone — even as the company secured a fresh patent win for its breast cancer vaccine technology in Mexico. The contrast is the week's defining tension. On April 29, the Mexican Institute of Industrial Property granted Anixa Biosciences a patent covering its breast cancer vaccine…
- Market cap
- $97M
- Next earnings
- 12 Jan 2027
Key data as of 12 Nov 2026

ANIX news and analysis
RSSNo long-form analysis yet for ANIX. Pulse alerts and the live data picture are available on ORTEX.
Open ANIX on ORTEX →Want the live picture for ANIX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANIX — free to start on ORTEX.
Sign up for free →Open ANIX on ORTEX